Infrequent expression of the MAGE gene family in uveal melanomas
Authors:
- 11 June 1996
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 66 (6) , 738-742
Abstract
It has previously been reported that MAGE‐1, ‐2, ‐3 and ‐4 genes are expressed in human cancers including cutaneous melanoma. MAGE‐1 and MAGE‐3 represents targets for specific immunotherapy because they encode peptide antigens which are recognised by cytotoxic T lymphocytes (CTL) when presented by HLA class I molecules, and pilot clinical trials with these peptides are currently in progress. It is likely that other members of the MAGE gene family may also encode antigens recognised by CTL. Uveal melanomas, like cutaneous melanomas, arise from melanocytes that are derived from the neural crest. To determine if uveal melanoma patients would be suitable for MAGE‐peptide immunotherapy, the expression of MAGE‐1, ‐2 ‐3 and ‐4 genes was assessed by reverse transcription followed by polymerase chain reaction (RT‐PCR) amplification and ethidium bromide staining. Expression of MAGE genes was not detected in any of 27 primary tumours. Either MAGE‐1 or MAGE‐4 was expressed in only 2 of 26 metastatic samples, but expression of MAGE‐2 or ‐3 was not detected. Our data suggest that, unlike cutaneous melanomas, uveal melanomas may not be suitable candidates for MAGE‐peptide immunotherapy. © 1996 Wiley‐Liss, Inc.Keywords
This publication has 22 references indexed in Scilit:
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.Journal of Experimental Medicine, 1994
- Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.Proceedings of the National Academy of Sciences, 1994
- Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.Journal of Experimental Medicine, 1994
- Sequence and expression pattern of the human MAGE2 geneImmunogenetics, 1994
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.Journal of Experimental Medicine, 1993
- Letter to the editorInternational Journal of Cancer, 1992
- Epidemiologic aspects of uveal melanomaSurvey of Ophthalmology, 1988
- Prognostic Factors in Choroidal and Ciliary Body MelanomasArchives of Ophthalmology (1950), 1977